1. Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein
   Pulak R. Manna et al, 2022, Biomedicines CrossRef
2. Contribution of nucleophosmin overexpression to multidrug resistance in breast carcinoma
   Siying Chen et al, 2018, Journal of Drug Targeting CrossRef
3. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
   Jin Liu et al, 2020, Bioscience Reports CrossRef
4. Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
   Faria Sultana et al, 2020, Current Medicinal Chemistry CrossRef
5. Valproic Acid and Breast Cancer: State of the Art in 2021
   Anna Wawruszak et al, 2021, Cancers CrossRef
6. Histone deacetylase inhibitors (HDACi), the ongoing epigenetic agents to enhance chemotherapy sensitization
   Huanran Sun et al, 2021, Epigenetic Regulation in Overcoming Chemoresistance CrossRef
7. Research Progress of HDACs Family in Breast Cancer
   豪芳 苑, 2023, Advances in Clinical Medicine CrossRef
8. Effective PI3K modulators for improved therapy against malignant tumors and for neuroprotection of brain damage after tumor therapy (Review)
   Satoru Matsuda et al, 2016, International Journal of Oncology CrossRef
9. Nucleophosmin/B23 contributes to hepatic insulin resistance through the modulation of NF-κB pathway
   Xiaohua Wang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
10. The effects of SAHA on radiosensitivity in pancreatic cancer cells by inducing apoptosis and targeting RAD51
    Zhibing Wu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
11. Kanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells
    Xian-Wen Zhang et al, 2017, Experimental and Therapeutic Medicine CrossRef